76,89,90 In this regard,
reduced Treg-cell suppression after stimulation with various purified microbial ligands suggests that classical vaccine adjuvants derived from crude microbial preparations may simulate immune activation by overriding Treg-mediated immune suppression. Indeed, the transient ablation of Foxp3+ cells alone during stimulation with purified peptide is sufficient to trigger the robust activation, expansion and formation of memory CD8+ T cells, which confers protection against subsequent Listeria infection in an antigen-specific fashion.88 Similarly, Foxp3+ cell ablation augments the expansion and activation of antigen-specific CD8+ T-cells primed by the live attenuated viral vector modified vaccinia virus Ankara.91 These findings are consistent with the enhanced vaccine-induced immunogenicity RXDX-106 nmr that occurs with Treg-cell ablation using anti-CD25 antibody treatment, and the sustained priming of protective CD8+ T cells by attenuated Listeria even in mice lacking all known signal 3 inflammatory cytokines.92–97
Hence, overriding immune suppression by SB525334 order Treg cells probably plays pivotally important roles in stimulating protective T-cell responses in vivo. However, while immune adjuvants and vaccine vectors have traditionally been evaluated for their ability to activate T cells indirectly through stimulation of professional APCs that in turn elaborate defined stimulation signals [T-cell receptor (signal 1), co-stimulation (signal 2), and inflammatory cytokines (signal 3)],95,97,98 overriding active suppression by Treg cells probably represents a more fundamental prerequisite ‘signal zero’ essential for stimulating effector T-cell activation in vivo. Although this term has recently been used to describe the activation of innate immunity or chemokine gradients that each also participate selleck screening library in T-cell activation,99,100 we propose that this descriptor is more appropriate for overriding
the impacts of suppression mediated by Treg cells and other immune suppressive cells, which actively restrains T-cell activation (Fig. 1). Since the identification of Treg cells as a separate and defined lineage of CD4+ T cells, there has been an explosion of studies describing the role these cells play in almost every aspect of the immune response. With the establishment of Foxp3 expression as the lineage-specific marker for Treg cells and the development of transgenic mouse tools for manipulating Foxp3+ cells in vivo, newfound protective roles for these cells in host defence against some infections have been uncovered. In turn, for other infections, the detrimental roles played by Foxp3+ cells in host defence have been reinforced.